Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

Investigator-led COVID-19 study in South Korea

One research site was initiated at the end of May, 2020, and two sites were initiated in early June for the investigator-led COVID-19 phase 2 trial in South Korea. Dr. Dong Sik Jung, professor, in the division of infectious disease of Dong-A University Hospital, has now begun the process of screening patients.


https://www.stockwatch.com/News/Item?bid=Z-C%3AAGN-2925712&symbol=AGN®ion=C
Research institutions


I'm disappointed with SK's results thru Novotech too. Expected completed research as planned. SKoreans are usually very prompt and take responsibilities for plans and promises. I feel we may still see results even at these late dates.

Novotech and GVI apparently have the contacts for patients in many of the hot spots for COVID. I feel the initial IPF trial should fill fast too and cant see any reason for delays awaiting countries or states where enrollments may be slow.
With the building science from sources to back Dr William's research there should be plenty of impetus to be moving ASAP...